<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We investigated the cause of <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> and proliferation of megakaryocytes in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> with <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-MF (+)) </plain></SENT>
<SENT sid="1" pm="."><plain>Plasma-transforming growth factor-beta1 (PTGF-beta1) concentrations closely correlated with <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> grade in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-MF (+) and were higher than those in idiopathic <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> (IMF), <z:e sem="disease" ids="C0040028" disease_type="Disease or Syndrome" abbrv="">essential thrombocythemia</z:e> (ET), <z:hpo ids='HP_0001973'>idiopathic thrombocytopenic purpura</z:hpo> (<z:chebi fb="0" ids="16039">ITP</z:chebi>), <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-without MF (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-MF (-)) or healthy volunteers (HV) </plain></SENT>
<SENT sid="2" pm="."><plain>Peripheral blood mononuclear cells from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-MF (+) patients expressed more TGF-beta1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> than those from IMF, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-MF (-) or HV </plain></SENT>
<SENT sid="3" pm="."><plain>When we immunostained bone marrow specimens of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-MF (+) for TGF-beta, the intensity of blasts was apparently higher than that of megakaryocytes, while in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-MF (-), megakaryocytes were immunostained with a similar intensity as that in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-MF (+), but blasts were negative for staining </plain></SENT>
<SENT sid="4" pm="."><plain>In IMF, megakaryocytes, monocytes and small mononuclear cells representing CD34+ cells were <z:hpo ids='HP_0000001'>all</z:hpo> similarly stained with a much lower intensity than that of blasts in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-MF (+) </plain></SENT>
<SENT sid="5" pm="."><plain>The number of bone marrow megakaryocytes were increased the most in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-MF (+), followed by ET, <z:chebi fb="0" ids="16039">ITP</z:chebi>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-MF (-) and NHL and correlated with plasma thrombopoietin (TPO) levels or with plasma TGF-beta1 levels, respectively, in each disease </plain></SENT>
<SENT sid="6" pm="."><plain>Thus, in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-MF (+), both <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> and the increased megakaryocytes were ascribed to overproduction of TGF-beta1 from blasts </plain></SENT>
</text></document>